Group items tagged

Netscribes latest market research report titled Business Intelligence and Analytics Market in India 2014 captures the current scenario of the Business Intelligence and Analytics market in India. Continual rise in trading and business activity across the globe has resulted in the formulation of vast amount of digital data, which if analyzed efficiently can produce valuable insights and statistics.

The solutions in the Global Intelligent Video Analytics market are generally built on two different types of architecture: server-based and edge-based. Although some vendors differentiate slightly in the solution implementation type, all video analytics can be implemented in the above mentioned predominant architectures.

Analysis of leukemia business development enables tracking cutting edge companies, therapies and new technologies. Analysis of key areas of pharmaceutical R&D helps identify emerging leukemia products. The tool is designed in a way to assist in finding right partners, optimizing licensing deals and choosing projects that give the best competitive advantage.

Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go off patent before 2012, comprising Aventis Taxotere (docetaxel), Bristol-Myers Squibbs Paraplatin (carboplatin) and Eli Lillys Gemzar (gemcitabine). The third-generation chemotherapeutic agents have expanded the therapeutic options in the treatment of advanced lung cancer. However, despite their contributions, science has reached a therapeutic plateau.

Analytical tools to analyses antibodies and peptides in oncology lead to analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug competitive landscape. A progress analysis on current and emerging drugs for cancer antibodies in oncology lays down a comprehensive framework for further analysis of the field.

The tool on apoptosis in oncology also assists in analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future.

A progress analysis on current and emerging drugs on the peptide drug development the reveals promising investment opportunities. Popular products included in the package are Cancer Peptides: From First-in-Class to Best-in-Class; and Peptides in Oncology Drug Pipeline Update 2013.